Type 2 diabetes mellitus, cerebral small vessel disease and depressive disorders

Patients with type 2 diabetes mellitus (T2DM) have a significantly higher risk of developing depressive disorders compared to individuals without impaired carbohydrate metabolism. In the context of population aging and the increasing prevalence of T2DM, there is an urgent need to better understand the mechanisms that determine the relationship between diabetes and brain disease. Depressive disorders and T2DM often share genetic, behavioral, and psychosocial risk factors. However, it is still unclear whether depression is associated with an increased risk of developing a wide range of cardiovascular diseases in patients with T2DM, and whether metabolic biomarkers may mediate these associations. Existing scales for assessing cardiovascular risk demonstrate insufficient accuracy in prediction, which prompts the search for new, more objective markers, one of which is arterial stiffness. Cognitive impairment and depressive disorders in T2DM are likely to have different underlying pathophysiological mechanisms. However, one of the common mechanisms may be microvascular dysfunction, namely cerebral small vessel disease (CSVD). Signs of CSVD progress linearly with the development of the condition, from the physiological state of glucose metabolism to prediabetes and T2DM, which correlates with glycemic levels even at the stage of prediabetes. There is a hypothesis that CSVD may serve as an early and determinant mechanism for the development of depressive disorders, especially among elderly patients. However, data on CSVD and arterial stiffness in patients with T2DM and comorbid depressive disorders remain limited. The aim of this review was to discuss the specifics of the relationships between T2DM, cerebral small vessel disease, arterial stiffness, and depressive disorders, as well as to analyze new trends and directions for future research. The search was conducted in Scopus, Science Direct (from Elsevier) and PubMed, including MEDLINE, databases. The keywords used were “diabetes mellitus”, “cerebral small vessel disease”, “arterial stiffness”, and “depressive disorders.” A manual search of the bibliography of publications was used to identify research results that could not be found during the online search.

Authors

Institutions

Publication Details

Journal
INTERNATIONAL NEUROLOGICAL JOURNAL
Published
2025-05-20
DOI
https://doi.org/10.22141/2224-0713.21.3.2025.1178
Citations
7
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
8.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Type 2 diabetes mellitus, cerebral small vessel disease and depressive disorders

Victoria Serhiyenko, O.М. Chemerys, A.A. Serhiyenko, V.І. Pankiv
7 citations
INTERNATIONAL NEUROLOGICAL JOURNAL
Diet and metabolism studies
8.15
article

Type 2 diabetes mellitus, cerebral small vessel disease and depressive disorders

Victoria Serhiyenko, O.М. Chemerys, A.A. Serhiyenko, V.І. Pankiv
article en
7 citations

Abstract

Patients with type 2 diabetes mellitus (T2DM) have a significantly higher risk of developing depressive disorders compared to individuals without impaired carbohydrate metabolism. In the context of population aging and the increasing prevalence of T2DM, there is an urgent need to better understand the mechanisms that determine the relationship between diabetes and brain disease. Depressive disorders and T2DM often share genetic, behavioral, and psychosocial risk factors. However, it is still unclear whether depression is associated with an increased risk of developing a wide range of cardiovascular diseases in patients with T2DM, and whether metabolic biomarkers may mediate these associations. Existing scales for assessing cardiovascular risk demonstrate insufficient accuracy in prediction, which prompts the search for new, more objective markers, one of which is arterial stiffness. Cognitive impairment and depressive disorders in T2DM are likely to have different underlying pathophysiological mechanisms. However, one of the common mechanisms may be microvascular dysfunction, namely cerebral small vessel disease (CSVD). Signs of CSVD progress linearly with the development of the condition, from the physiological state of glucose metabolism to prediabetes and T2DM, which correlates with glycemic levels even at the stage of prediabetes. There is a hypothesis that CSVD may serve as an early and determinant mechanism for the development of depressive disorders, especially among elderly patients. However, data on CSVD and arterial stiffness in patients with T2DM and comorbid depressive disorders remain limited. The aim of this review was to discuss the specifics of the relationships between T2DM, cerebral small vessel disease, arterial stiffness, and depressive disorders, as well as to analyze new trends and directions for future research. The search was conducted in Scopus, Science Direct (from Elsevier) and PubMed, including MEDLINE, databases. The keywords used were “diabetes mellitus”, “cerebral small vessel disease”, “arterial stiffness”, and “depressive disorders.” A manual search of the bibliography of publications was used to identify research results that could not be found during the online search.

INTERNATIONAL NEUROLOGICAL JOURNALVol. 21(3)
Danylo Halytsky Lviv National Medical University (UA), Ministry of Health (UA)
Openalex Percentile: Top 2%
Diet and metabolism studies
8.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.